Breaking News, Collaborations & Alliances

Quanticate Links Up with Lancaster University

Quanticate to research optimizing clinical trial design for rare disease and the role of response-adaptive randomisation

Quanticate is partnering with Lancaster University to sponsor a STOR-i PhD project. The partnership will see Quanticate support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomisation. STOR-i was established in 2010 as an Engineering and Physical Sciences Resaearch Council EPSRC Centre for Doctoral Training and has developed an international reputation for the quality of its research. Karen Ooms, executive vice president for c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters